These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9613453)

  • 41. Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis.
    Xie Y; Zhang H; Sheng W; Xiang J; Ye Z; Yang J
    Cancer Lett; 2008 Nov; 271(1):105-16. PubMed ID: 18789575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.
    Shi J; Zheng D; Liu Y; Sham MH; Tam P; Farzaneh F; Xu R
    Cancer Res; 2005 Mar; 65(5):1687-92. PubMed ID: 15753363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histologic aspects of concomitant resistance induced by nonimmunogenic murine tumors.
    Meiss RP; Bonfil RD; Ruggiero RA; Pasqualini CD
    J Natl Cancer Inst; 1986 Jun; 76(6):1163-75. PubMed ID: 3458952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Concomitant antitumor resistance].
    Ruggiero RA; Di Gianni PD; Franco M; Bustuoabad OD
    Medicina (B Aires); 1996; 56 Suppl 1():57-64. PubMed ID: 9224975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of apoptosis in the inhibition of a secondary tumor by concomitant resistance in a mouse model of metastases.
    Franco M; Bekinschtein P; di Gianni P; Bustuoabad OD; Vanzulli S; Ruggiero RA
    Medicina (B Aires); 1996; 56(4):393-6. PubMed ID: 9138345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of surgery on the cell kinetics of residual tumor.
    Simpson-Herren L; Sanford AH? ; Holmquist JP
    Cancer Treat Rep; 1976 Dec; 60(12):1749-60. PubMed ID: 1026333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of a new permanent squamous carcinoma line from human lung B 109.
    Stark M; Höhr D; Usmiani J
    Anticancer Res; 1988; 8(2):263-8. PubMed ID: 3284452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases control.
    Ruggiero RA; Bruzzo J; Chiarella P; Bustuoabad OD; Meiss RP; Pasqualini CD
    Cancer Res; 2012 Mar; 72(5):1043-50. PubMed ID: 22315349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two different types of concomitant resistance induced by murine tumors: morphological aspects and intrinsic mechanisms.
    Franco M; Bustuoabad OD; Di Gianni PD; Meiss RP; Vanzulli S; Buggiano V; Pasqualini CD; Ruggiero RA
    Oncol Rep; 2000; 7(5):1053-63. PubMed ID: 10948338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tyrosine isomers mediate the classical phenomenon of concomitant tumor resistance.
    Ruggiero RA; Bruzzo J; Chiarella P; di Gianni P; Isturiz MA; Linskens S; Speziale N; Meiss RP; Bustuoabad OD; Pasqualini CD
    Cancer Res; 2011 Nov; 71(22):7113-24. PubMed ID: 22084446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro determination of thymidine-3H labeling index in human solid tumors.
    Livingston RB; Ambus U; George SL; Freireich EJ; Hart JS
    Cancer Res; 1974 Jun; 34(6):1376-80. PubMed ID: 4363655
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of corticosteroid hormones in the control of cell proliferation in residual tumor after surgical cytoreduction.
    Braunschweiger PG; Ting HL; Schiffer LM
    Cancer Res; 1983 Dec; 43(12 Pt 1):5801-7. PubMed ID: 6640531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Action of demecolcine (colcemid) in the murine sarcoma 180 tumor.
    Nomura T; Plager JE
    Cancer Treat Rep; 1981; 65(3-4):283-90. PubMed ID: 7237451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two competing influences that may explain concomitant tumor resistance.
    Prehn RT
    Cancer Res; 1993 Jul; 53(14):3266-9. PubMed ID: 8324737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative determination of disseminated tumor cells by [3H]thymidine incorporation in vitro and by agar colony formation.
    Schirrmacher V; Waller CA
    Cancer Res; 1982 Feb; 42(2):660-6. PubMed ID: 7034926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concomitant tumor resistance.
    Chiarella P; Bruzzo J; Meiss RP; Ruggiero RA
    Cancer Lett; 2012 Nov; 324(2):133-41. PubMed ID: 22634498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VIP inhibits the proliferation of small-cell and nonsmall-cell lung carcinoma.
    Maruno K; Said SI
    Ann N Y Acad Sci; 1996 Dec; 805():389-92; discussion 392-3. PubMed ID: 8993419
    [No Abstract]   [Full Text] [Related]  

  • 59. Tumor dependence of observed thymidine index as a function of emulsion exposure.
    Lloyd HH; Simpson-Herren L
    Cancer Res; 1983 Mar; 43(3):1138-44. PubMed ID: 6825086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis.
    Gueron G; Anselmino N; Chiarella P; Ortiz EG; Lage Vickers S; Paez AV; Giudice J; Contin MD; Leonardi D; Jaworski F; Manzano V; Strazza A; Montagna DR; Labanca E; Cotignola J; D Accorso N; Woloszynska-Read A; Navone N; Meiss RP; Ruggiero R; Vazquez E
    Cell Death Dis; 2018 Feb; 9(2):140. PubMed ID: 29396431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.